Cellevolve Announces Expansive Global Collaboration with Seattle Children’s Therapeutics to Advance Research for Childhood Brain Cancers
SAN FRANCISCO & SEATTLE--(BUSINESS WIRE)--Cellevolve Bio (“the Company” or “Cellevolve”), a development and commercialization company focused on cell therapies and Seattle Children’s Therapeutics, a venture at Seattle Children's, bringing cutting edge, curative technologies and therapies to defeat pediatric cancer and other diseases that impact children, today announced a collaboration aimed...
